# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cingulate Inc. (the "Company") (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Rel...
Twelve Required Registration Batches CompletedNew Drug Application Being Prepped for Submission
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application CTx-1301 Could Benefit >60% of ADHD P...